People Background Check
Find People:

Robert H Schloemer Deceased17015 W Carmel Dr, Surprise, AZ 85387

Get Report
Known as:
Robert H Schoemer Bob H Schloemer Robt H Schloemer Rob H Schloemer
Related to:
Marielouise Louise Schloemer

Robert Schloemer Phones & Addresses

17015 W Carmel Dr, Surprise, AZ 85387 (317) 626-1170

15038 Cooperstown Way, Surprise, AZ 85374 (623) 374-2398

Albuquerque, NM

Westfield, IN

1735 Sweet Gum Dr, Indianapolis, IN 46260 (317) 872-0298

Maricopa, AZ

17015 W Carmel Dr, Surprise, AZ 85387 (317) 872-0298

Show more

Education

Degree: Graduate or professional degree

Mentions for Robert H Schloemer

Publications & IP owners

Wikipedia

Robert Schloemer Photo 18

Graef Anhalt Schloemer And Associates Inc. The Free ...

It was founded in 1961 by Luther W. Graef, Leonard Anhalt and Robert Schloemer. Graef, Anhalt, Schloemer & Associates, Inc. and the Milwaukee Art Museum's ...

Us Patents

Methods And Compositions For Liver Specific Delivery Of Therapeutic Molecules Using Recombinant Aav Vectors

US Patent:
2003016, Sep 4, 2003
Filed:
Mar 28, 2002
Appl. No.:
10/109799
Inventors:
Arun Srivastava - Indianapolis IN, US
Selvarangan Ponnazhagan - Cleveland OH, US
Robert Schloemer - Indianapolis IN, US
Xu-Shan Wang - Carmel IN, US
Mervin Yoder - Indianapolis IN, US
Jaime Escobedo - Alamo CA, US
Varavani Dwarki - Alameda CA, US
Assignee:
Chiron Corporation - Emeryville CA
International Classification:
A61K048/00
C12N015/861
US Classification:
435/456000, 424/093200
Abstract:
Provided are methods for selectively expressing therapeutic molecules, such as secretory proteins, antisense molecules and ribozymes, in the liver. The methods find use in treating hepatic diseases or conditions. The methods also find use in treating any disease or condition in which systemic administration of the therapeutic substance, for example, a secretory protein, is desired. The methods involve administering to a mammalian patient having a need for liver expression of a therapeutic molecule an AAV vector containing a therapeutically effective amount of the therapeutic molecule. Also provided are novel vectors employable in these methods.

Methods And Compositions For Liver Specific Delivery Of Therapeutic Molecules Using Recombinant Aav Vectors

US Patent:
2001005, Dec 13, 2001
Filed:
Jul 24, 2001
Appl. No.:
09/912680
Inventors:
Arun Srivastava - Indianapolis IN, US
Selvarangan Ponnazhagan - Cleveland OH, US
Robert Schloemer - Indianapolis IN, US
Xu-Shan Wang - Carmel IN, US
Mervin Yoder - Indianapolis IN, US
Jaime Escobedo - Alamo CA, US
Varavani Dwarki - Alameda CA, US
Assignee:
Chiron Corporation.
International Classification:
A61K048/00
C12N015/861
US Classification:
514/044000, 435/320100
Abstract:
Provided are methods for selectively expressing therapeutic molecules, such as secretory proteins, antisense molecules and ribozymes, in the liver. The methods find use in treating hepatic diseases or conditions. The methods also find use in treating any disease or condition in which systemic administration of the therapeutic substance, for example, a secretory protein, is desired. The methods involve administering to a mammalian patient having a need for liver expression of a therapeutic molecule an AAV vector containing a therapeutically effective amount of the therapeutic molecule. Also provided are novel vectors employable in these methods.

Possible Relatives

J Schloemer  Jeff P Schloemer  John R Schloemer  Michael P Schloemer  Robert R Last  Robert C Stanbery  Robert C Standard  Robert E Standefer  Robert R Standfield  Robert J Stangel 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.